Servier – Phlebolymphology

Michel PERRIN

Dear Readers,

At the end of 2015, Servier asked me to become the editor-in-chief of Phlebolymphology. I accepted without hesitation as in the last two decades Phlebolymphology has become an excellent journal, particularly in terms of research updates and the treatment of venous and lymphatic disease. The Phlebolymphology website also lists:

• All randomized control trials regarding treatment of varicose veins, classified either by author or topic, plus their abstracts.
• The references of all articles published since 1990 on the presence of varices after operative treatment (PREVAIT), under 8 headings.

Randomized control trials on operative management of varicose veins and information on PREVAIT are both excellent tools for updating the knowledge of physicians who treat venous and lymphatic diseases and are particularly helpful for those who want to publish on these two topics.

Françoise Pitsch managed Phlebolymphology for more than 15 years by carefully selecting the articles to be published and I will do my best to continue this policy. As Servier informed me that the board contracts were over, I decided to revitalize the board by inviting younger people to sit on the board, and three women have agreed:
– Marianne de Maeseneer, Erasmus Medical Center, Rotterdam, Netherlands, who is in charge of the venous section of the European Journal of Vascular and Endovascular Surgery and an expert in the recurrence of varicose veins after operative treatment.
– Lourdes Reina Gutiérrez, Cruz Roja Hospital, Madrid, who has developed the use of ultrasound-guided sclerotherapy in Spain.
– Marzia Lugli, Hesperia Hospital, Modena, Italy, who has extensive European experience in treating deep venous obstruction.
These three Graces are joined by five male colleagues:
– Athanasios Gianoukas, University Hospital and University of Thessaly Medical School, Larissa, Greece, who is the general secretary of the European Venous Forum and who has wide-ranging experience in both acute and chronic venous disease.
– Oscar Maleti, Hesperia Hospital, Modena, Italy, who directs the Interuniversity Center of Phlebolymphology and has internationally recognized experience in treating deep venous reflux.
– Armando Mansilha, Faculty of Medicine, Angiology and Vascular Surgery, Porto, Portugal, who is an expert in venous surgery as well angiology.
– Djordje Radak, Faculty of Medicine, Vascular Surgery, Belgrade, Serbia, who has many publications to his credit.
– Marc Vuylsteke, Sint-Andriesziekenhuis, Tielt, Belgium, who has vast experience in vascular surgery and in thermal ablation of varicose veins.

I am convinced that all of the new board members will help me to track down the most appropriate authors to write articles of excellence for publication in Phlebolymphology.

Happy reading.
Michel Perrin